Brandon Yaras
CIK: 0002156611
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ATYR
aTYR PHARMA INC
Officer
Discretionary Trading P&L
Holdings
About Yaras Brandon
Yaras Brandon (SEC CIK 0002156611) files insider reports with the SEC as Chief Financial Officer of aTYR PHARMA INC (ATYR).
Signal8 holds 2 ownership filings by Yaras Brandon (1 Form 3, 1 Form 4), filed on Oct 1, 2026. Those filings report 1 transaction, the latest on Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Yaras Brandon's filings is in SAN DIEGO, CA.
Recent filings by Yaras Brandon
- Oct 1, 2026: Grant or award of ATYR derivative securities (Form 4, code A).
Other insiders filing for aTYR PHARMA INC (ATYR)
- SCHIMMEL PAUL, Director
- Coughlin Timothy, Director
- BENEVICH ERIC, Director
- Gross Jane A, Director
- Lucas Svetlana, Director
- Zaknoen Sara, Director